Assembled from the company's filings and exchange data as of today. Download PDF renders this page on the server; the narrative sections arrive with the Nexa composer.
Dossier · DHARTI PROTEINS LIMITED · 29 October 2026Page 1 of 3
Company Dossier
MarketPing Research · factual · no rating expressed
DHARTI PROTEINS LIMITED BSE: 531171
DHARTI PROTEINS LIMITED
State— filed
Last close · 29 Oct 2026₹114.38
Market cap—
TTM P/E · P/B · EV/EBITDA— · — · —
DHARTI PROTEINS LIMITED is a listed company. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.
What a broker report prints here — the analyst's thesis. This dossier prints the filed record instead; the narrative read of the latest results, the guidance ledger and the earnings-call summary are the composer's sections (INSTITUTIONAL-PLAN.md M3) and are not yet produced.
Exhibit 1: Financial summary, – (all audited; no estimate years)
₹ crore · consolidated
Revenue
EBITDA (ex other income)
margin %
Owners' profit
EPS, as reported (₹)
ROE % · ROCE %
Debt / equity (x)
Cash from operations
Capex
Source: SEBI results XBRL as filed with BSE/NSE; EBITDA excludes other income.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · DHARTI PROTEINS LIMITED · 29 October 2026Page 2 of 3
Exhibit 2: Quarterly performance, last 0 quarters
₹ crore
Revenue
Profit before tax
Net profit
EPS (₹)
Source: quarterly results as filed; the balance sheet is filed half-yearly and is not repeated here.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · DHARTI PROTEINS LIMITED · 29 October 2026Page 3 of 3
Exhibit 3: Filings of the last 90 days, with the measured price reaction
Date · filing
Category
Importance
Next day %
5-day %
15 Oct 2026 · 4th Monitoring Committee meeting outcome filed with BSE
regulatory legal
medium
—
—
14 Oct 2026 · Dharti Proteins publishes EOGM notice in newspapers
compliance
minimal
—
—
14 Oct 2026 · Newspaper publication of Q2 and half year FY26 audited results
compliance
minimal
—
—
13 Oct 2026 · EGM on Nov 6 to issue bonus shares to public for MPS compliance
board shareholder meetings
low
—
—
13 Oct 2026 · Board recommends 1:1 bonus shares to public shareholders to meet MPS norms
corporate actions
high
—
—
13 Oct 2026 · Bonus issue 1:1 to public shareholders, Q2 profit Rs 337 lakh, new tax auditor
management changes
low
—
—
13 Oct 2026 · Q2 profit Rs 322.96L came from MD loan waiver; 1:1 bonus to public
results
high
—
—
13 Oct 2026 · Dharti Proteins Q2 profit jumps; 1:1 bonus to public shareholders
results
high
—
—
13 Oct 2026 · Bonus 1:1 for public, Q2 PAT Rs 337L driven by MD loan waiver
results
high
—
—
8 Oct 2026 · Trading window closed; company considers bonus issue
compliance
minimal
—
—
Source: exchange announcements; each reaction is measured from the close before the filing. Next day = the close one session after the reaction day (the first session that could trade the filing).
How to read this document
Where a broker report shows
This document shows
Why
A rating (BUY / ADD / REDUCE / SELL)
A state: the latest filed quarter and the measured reactions
an event is a fact; a rating is an opinion that requires SEBI RA registration
A target price and upside
The current price and the multiples against the group
a target is a forecast; a multiple is a measurement
Estimate years marked E
More audited years; no estimates
MarketPing publishes no forecasts — your own model lives on the Models page
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
